CSF-1 recruits MDSCs with the ability to support tumor immune escape by binding to CSF-1R expressed by MDSCs, and studies demonstrated that selective inhibitors PLX3397 and GW2580 could block their signaling by targeting CSF-1R (Priceman et al., 2010; Mok et al., 2014). Here, CSF1R is linked to neoplasm.